@GubinMatthew presents his work on neoantigen vaccines and checkpoint therapy. Strong contributions from @kesharisunita @ekta_saha Alex Shavkunov and @AverySalmon15.
Congratulations to the 2022 class of Andrew Sabin Family Fellows, a diverse group of early-career researchers poised to pursue potentially practice-changing science: https://t.co/pTkTajX5nq @May_Daher@GubinMatthew@Humam_Kadara#EndCancer
#ICYMI: BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and #Immune Checkpoint-Therapy Efficacy by Salmon, Shavkunov, Gubin et al.
https://t.co/O0Hf0Ox4IF
@GubinMatthew@MDAndersonNews@parkerici